Zhou Yue, Zhang Yuezhi, Shi Ke, Wang Changyun
Department of Ophthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Medicine (Baltimore). 2017 Jun;96(22):e6754. doi: 10.1097/MD.0000000000006754.
Diabetic retinopathy (DR) is a frequent cause of acquired blindness worldwide. Various studies have reported the effects of body mass index (BMI) on the risk of DR, but the results remain controversial. Therefore, a meta-analysis was performed to evaluate the relationship between BMI and the risk of DR.A systematic search was performed using the Cochrane Library, PubMed, and Embase databases to obtain articles published through December 2016. Articles regarding the association between BMI and the risk of DR were retrieved. The adjusted odds ratios (ORs) and their 95% confidence intervals (CIs) were included and then pooled with a random effects model.A total of 27 articles were included in this meta-analysis. When BMI was analyzed as a categorical variable, neither being overweight (OR = 0.89, 95% CI 0.75-1.07; P = .21; I = 65%) nor obesity (OR = 0.97, 95% CI 0.73-1.30; P = .86) were associated with an increased risk of DR when compared with normal weight. When BMI was analyzed as a continuous variable, a higher BMI was not associated with an increased risk of DR (OR = 0.99, 95% CI 0.97-1.01; P = .25; I2 = 79%). The pooled results did not significantly change after the sensitivity analysis.Based on the current publications, neither being overweight nor obesity is associated with an increased risk of DR. Further studies should confirm these findings.
糖尿病性视网膜病变(DR)是全球范围内后天性失明的常见原因。各种研究报告了体重指数(BMI)对DR风险的影响,但结果仍存在争议。因此,进行了一项荟萃分析以评估BMI与DR风险之间的关系。
使用Cochrane图书馆、PubMed和Embase数据库进行系统检索,以获取截至2016年12月发表的文章。检索了关于BMI与DR风险之间关联的文章。纳入调整后的比值比(OR)及其95%置信区间(CI),然后采用随机效应模型进行汇总。
本荟萃分析共纳入27篇文章。当将BMI作为分类变量进行分析时,与正常体重相比,超重(OR = 0.89,95%CI 0.75 - 1.07;P = 0.21;I² = 65%)和肥胖(OR = 0.97,95%CI 0.73 - 1.30;P = 0.86)均与DR风险增加无关。当将BMI作为连续变量进行分析时,较高的BMI与DR风险增加无关(OR = 0.99,95%CI 0.97 - 1.01;P = 0.25;I² = 79%)。敏感性分析后汇总结果无显著变化。
基于当前的出版物,超重和肥胖均与DR风险增加无关。进一步的研究应证实这些发现。
Medicine (Baltimore). 2017-6
Cochrane Database Syst Rev. 2017-12-22
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2018-1-29
Cochrane Database Syst Rev. 2025-5-7
Cochrane Database Syst Rev. 2007-1-24
Cochrane Database Syst Rev. 2022-11-17
Cochrane Database Syst Rev. 2018-7-24
J Vitreoretin Dis. 2024-2-13
JMIR Public Health Surveill. 2024-2-6
Int J Ophthalmol. 2023-8-18
Int J Retina Vitreous. 2016-9-12
Prev Med Rep. 2015-7-18
Can J Diabetes. 2015-3-30
Diabetes Metab Syndr. 2011